PLIANT THERAPEUTICS, INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-149.3M | $-210.3M | $-161.3M | $-123.3M | $-97.3M | $-41.5M | $-631.0K |
| Depreciation & Amortization | — | — | — | — | — | — | — |
| Depreciation | $1.7M | $2.1M | $1.8M | $1.8M | $1.5M | $1.3M | $1.1M |
| Amortization | — | — | — | — | — | — | — |
| Stock-Based Compensation | $26.2M | $37.6M | $44.5M | $22.6M | $10.4M | $3.9M | $1.8M |
| Net Cash from Operating Activities | $-128.3M | $-155.5M | $-116.4M | $-94.6M | $-75.4M | $-37.3M | $-2.8M |
| Investing Activities | |||||||
| Capital Expenditures | $374.0K | $3.8M | $921.0K | $1.8M | $2.0M | $1.5M | $964.0K |
| Business Acquisitions | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $134.3M | $140.3M | $-127.0M | $-150.2M | $73.7M | $-210.9M | $-17.9M |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-31.7M | $23.1M | $274.4M | $226.9M | $2.5M | $213.2M | $45.5M |
| Net Change in Cash | $-25.7M | $8.0M | $31.0M | $-18.0M | $783.0K | $-34.9M | $24.9M |
| Free Cash Flow | $-128.7M | $-159.4M | $-117.3M | $-96.4M | $-77.4M | $-38.8M | $-3.7M |